November 13, 2024, 8:00 a.m. - 9:00 a.m. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients BBSRB 202A
Event Details
Article Link: